A B S T R A a . W e assessed the in vivo and in vitro effects of antibiotics and tin-protoporphyrin (TP) on intestinal heme oxygenase (HO) activity using a gas chromatographic assay. This method measures the carbon monoxide produced from heme in the presence of NADPH. After in vivo administration of kanamycin (10 mg/kg body weight), ampicillin (200 mg/kg body weight) or neomycin (60 mg/ kg body weight) with or without T P (65 pmol/kg body weight) to suckling rats, no significant difference in HO activity along the small intestine was observed. I n vitro exposure of adult rat intestinal preparations to the antibiotics showed no significant decrease in H O activity between control and experimental tissue preparations. A concentration-dependent stimulatory effect of neomycin was observed. Subcutaneous administration of T P (25 pmol/kg body weight) to adult male Wistar rats revealed no significant inhibition of the intestine. However, in vitro addition of T P (12.5 pM) to the control tissue preparations of adult Wistar rats revealed highly significant inhibition in liver and spleen when compared to the unexposed control tissues. In contrast, when T P was added to control intestinal preparations no inhibition was observed. These findings suggest that suckling rat intestinal heme oxygenase is not inhibited by in vivo treatment with high concentrations of kanamycin, ampicillin, or neomycin. Furthermore, these antibiotics are not in vitro inhibitors of adult rat intestinal HO. Finally, adult rat intestinal H O is not inhibited either in vivo or in vitro by a concentration of TP that significantly inhibits liver and spleen activity. (Pediatr Res 23: 50-53, 1988) Abbreviations CO, carbon monoxide TP, tin-protoporphyrin HO, heme oxygenase VeCO, excretion rate of C O TP, a synthetic heme analog, has been reported to be a competitive inhibitor of HO (1-3). This rate-limiting enzyme in the heme catabolic pathway (4) catalyzes the equimolar formation of bilirubin and CO. In vivo studies with TP have demonstrated the drug's effectiveness in lowering serum bilirubin levels in rats ( 3 , in mice with severe hemolytic anemia (6) in rhesus monkeys (7), and in man (8). Preliminary studies in our laboratory suggested that a single dose of TP has no suppressive effect on the excretion rate of CO (VeCO) in suckling rats (9, 10) unless
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MATERIALS AND METHODS
Animals. Wistar rats were used for all experiments. For neonate studies, litters of rats were received within 12 h postpartum. The average weight of the suckling rats was 6.25 g. Adult males of 250-300 g each were used for adult experiments. Neonates were allowed free access to their mother between treatments and adults were fed MRH 2215 Rodent Blox (Wayne Animal Diets, Chicago, IL) and water ad libitum. All animals were housed in a temperature-controlled room (24 * lo C) with a 12-h light cycle.
All animals were sacrificed by decapitation.
TP. TP was purchased from Porphyrin Products Inc. (Logan, UT), and was prepared as described previously (1 I), stored in the dark and used within 1 h of preparation.
Methemalbumin. Two concentrations of methemalbumin were used for these experiments. A 2.0/0.15 mM concentration was used for in vivo antibiotic-treated suckling HO determinations (Table 1) . Thirteen mg of hemin (Sigma Chemical Co., St. Louis, MO) were dissolved in 2.5 ml 0.4 M Na3PO4 Distilled water (6.5 ml) and 100 mg bovine serum albumin (Sigma) were added. The solution was gradually titrated to pH 7.4 with 10 N HCl under stirring. The volume was adjusted to 10 ml with distilled water and stored at 4°C for up to 1 month. A dilute (150/11.2 fiM) methemalbumin solution was used for studies assessing in vitro antibiotic treatment of adult intestinal homogenates (Table 3 ) and in vivo and in vitro TP treatment of adult rats (Table 2 ). This solution was prepared by diluting the solution described above with 0.1 M KP04, pH 7.4 (buffer).
NADPH. NADPH (4.0 mg), tetrasodium salt, 8.5% water, type I (Sigma) was dissolved in 1.0 mlO.l M KP04 buffer, pH 7.4.
Antibiotics. The antibiotic solutions used for the in vitro incubations with adult rat tissue supernatants were prepared as follows. Twenty-five times concentrated solutions were made by dissolving 100 mg neomycin sulfate (The Upjohn Company, Kalamazoo, MI), 2 1.2 mg ampicillin sodium (Wyeth Laboratories, Philadelphia, PA), and 1.0 mg kanamycin sulfate (Beecham Laboratories, Bristol, TN) per ml of 0.1 M KP04 buffer, pH 7.4.
These solutions were further diluted to 5x and I x with the appropriate amount of buffer. Twenty p1 of these solutions were
added to the reaction vials yielding final reaction medium concentrations (for the 25x solutions) of 25.0 mg neomycin/ml, 5.03 mg ampicillin/ml, and 0.25 mg kanamycin/ml. The antibiotics for the in vivo treatment of sucklings were similarly prepared in the following concentrations: 1.5 mg neomycin/ml, 250 mg ampicillin/ml, and 12.5 mg kanamycin/ml.
Tissue collection and preparation. Tissue supernatants were prepared for assay as follows.
Liver and Spleen. The organs were removed and washed with ice-cold buffer. Each organ was homogenized with a Biohomogenizer (Biospec Products, Inc, Bartlesville, OK) in 4 volumes of buffer and the preparations were centrifuged at 13,000 x g for 15 min. The supernatant was then analyzed.
Adult Intestine. The entire intestinal length was perfused with 20 ml of ice-cold buffer to remove the content. The intestine was then cut longitudinally into two equal sections. The mucosa was collected from one of the sections by gently scraping the tissue with a glass slide. The serosa was designated as what remained of the first section after the mucosa was removed. The second section was left intact and was referred to as "whole" in Tables  2 and 3 . The three intestinal fractions were homogenized in 4 volumes of buffer and centrifuged as described above.
Neonate Intestine. After removal of the small intestine, the entire length was perfused with 5-ml of ice cold buffer. Three sections of 3 cm each were excised corresponding to the duodenum, jejunum, and ileum. Due to the fragile nature of the intestine, the mucosa could not be collected in the same manner as for the adult tissues. Instead, the intestinal segments were simply homogenized in 4 volumes of buffer and centrifuged as described above.
HO assay. Traditionally, in vitro HO activity is determined using a spectrophotometric method that measures bilirubin production (4). However, for this study, we used a gas chromatographic assay that measures the amount of CO produced from methemalbumin in the presence of NADPH (16) (17) (18) . The procedure is a simplification of the method of Sunderman et al.
(1 9). Twenty p1 of the tissue preparation, 20 p1 of the appropriate methemalbumin solution, and either 20 p1 of NADPH (total) or buffer (blank) were placed in septum-sealed vials. For some studies, either antibiotics (20 p1) or TP (1.5 p1) was also added to vial. After a 5-min temperature equilibration, the vials were purged with CO-free air and allowed to incubate for 15 min at 37" C. The reaction was terminated by quick freezing the vials in a dry icelacetone bath (-78" C). The CO produced in the vials was then quantified by a gas chromatograph coupled to a Reduction Gas Detector (Trace Analytical Inc., Menlo Park, CA) with a sensitivity of 1 pmol/CO vial (18, 20) . CO production by total and blank, analyzed in duplicate, was calculated and HO activity is presented as the difference between total and blank reactions expressed as nmoles CO produced/h/mg protein.
As mentioned above, two concentrations of methemalbumin were used. Preliminary studies in our laboratory show that, due to competition, the effects of inhibitors such as TP may be reduced if the originally recommended (1 8) 2.0/0.15 mM methemalbumin solution is used for the assay. Inhibition is more clearly revealed when the less concentrated 15011 1.2 pM solution is utilized.
Protein determination. The supernatant protein concentration was determined by the method of Lowry et al. (21) . Bovine serum albumin (Sigma) was used as the standard.
Experimental procedure. In Vivo Antibiotic Treatment of Sucklings (Table I ) sulfate (60 mg/kg body weight) at t = 26 and 42 h. The salinetreated pups were injected and gavaged similarly with 0.9% NaC1.
The TP + antibiotic-treated group also received a single subcutaneous injection of 40 p1 of TP (65 pmol/kg) at t = 0 h. The rats were sacrificed at t = 48 h, when Posselt et a/.
(1 1) observed the greatest difference between the CO excretion rats of TPtreated and saline-treated pups.
In Vitro Antibiotic Studies of Adult Rat Tissues (Table 2) . Mucosal, serosal, and whole intestinal supernatants were obtained as described above from untreated adult Wistar rats. Heme oxygenase activity determinations were camed out as described above with 20 p1 of the appropriate antibiotic solution added to the reaction vial. The activities were compared with controls in which 20 p1 buffer had been added to the reaction vial in place of the antibiotics.
In Vivo TP Treatment of Adult Rats ( Table 3) . Adult male Wistar rats were injected subcutaneously with either 25 pmol TP/kg body weight (TP) or an equal volume of saline (control) at t = 0 h. Rats were sacrificed at t = 16 h and tissue preparation was carried out as described above.
In Vitro TP Treatment ofAdult Rat Tissues (Table 3) . Tissue preparations from control rats were used for these in vitro studies of HO activity; 1.5 p1 of a 0.5 mM TP solution were added to reaction vials containing supernatant, methemalbumin, and either buffer or NADPH. Heme oxygenase determinations were performed as described above.
Statistics. All values are expressed as mean + SD. Student's t test for independent and paired samples was used for statistical analysis of results.
RESULTS
After in vivo treatment of suckling rats (Table l) , no significant difference in HO activity in any segment of the intestine was observed between the three treatment groups (saline control, antibiotics, and TP + antibiotics). The activity gradient observed for the control group was maintained after the treatments. In vitro treatment of adult rat intestine preparations with neomycin, ampicillin, and kanamycin (Table 2) showed no significant decrease in HO activity between control and treated groups. A concentration-dependent stimulation of HO activity in both mucosa and whole intestine was observed after addition of neomycin. No significant inhibition of the adult rat intestine was observed after either in vivo subcutaneous treatment with TP or in vitro exposure to TP (Table 3) . However, adult rat liver HO activity was significantly inhibited after in vivo treatment with the same concentration, and both spleen and liver HO activities were significantly inhibited after in vitro exposure to the drug.
DISCUSSION
After in vitro addition of neomycin, ampicillin, and kanamycin to adult rat intestine preparations, no suppression of HO activity is observed. Our data also suggest that these antibiotics are not in vivo inhibitors of the suckling rat intestine. Saline (n = 6) 1.7 + 0.9 2.8 + 0. 9 p < 0.00 1 compared to control.
were only able to demonstrate inhibitory effect of TP, as measured by the VeCO, by first treating suckling Wistar rats with broad-spectrum antibiotics. Because undegraded heme is excreted into the intestine with the bile (12, 13) , two explanations were offered for the observed phenomenon. 1) The antibiotics had eradicated the heme-degrading, CO-producing bacteria ( 14) in the gut or 2) the antibiotics had directly inhibited intestinal HO. The present study, however, eliminates the possibility of T P treatment in animals that had prophylactically received broad-spectrum antibiotics did not exclude some measurable contribution to the VeCO by intestinal H O degradation of heme, reaching the intestine via the bile (12, 13) . However, the fact that the suppression of C O excretion could be appreciated only after antibiotics suggests that bacterial breakdown of heme was an important source of C O in animals not treated with antibiotics. This might be further interpreted as suggesting that a comparable amount of heme was not absorbed by the intestine, precluding intestinal heme oxygenase breakdown of heme. The possibility of heme breakdown by intestinal H O is important to consider because intestinal CO production from biliary heme could be coupled with bilirubin production by the H O in intestinal mucosal cells. This bilirubin could be absorbed into the circulation, thereby compromising the efficacy of T P for reducing serum bilirubin levels in neonates.
Because intestinal HO appears to be different in terms of its vulnerability to competitive inhibition by TP compared to the H O present in other tissues, we suggest that the disposition of biliary heme be carefully evaluated, especially in appropriate neonatal models, where the enterohepatic circulation is prominent in the transitional period after birth. Although even lower concentrations of T P than those used in these experiments may be effective at inhibiting H O in other tissues, such as the liver, heme diverted to the intestine could be degraded to CO and bilirubin because of the lack of H O inhibition in this tissue. In light of the presented results, oral administration of T P would not be a n effective solution. The enteral route, however, with direct intestinal absorption of TP, might still represent a feasible option for achieving effective inhibitory concentrations of T P in other sensitive organs.
